Estimating Daclizumab effects in Multiple Sclerosis using Stochastic Symmetric Nets
暂无分享,去创建一个
Beccuti Marco | Pernice Simone | Pernice Simone | Beccuti Marco | Do' Pietro | P. Marzio | Pappalardo Francesco | Pappalardo Francesco | Do' Pietro | Pennisi Marzio
[1] K. Chu,et al. New feasible treatment for refractory autoimmune encephalitis: Low-dose interleukin-2 , 2016, Journal of Neuroimmunology.
[2] Xavier Montalban,et al. Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta , 2010, The Lancet Neurology.
[3] Placido Bramanti,et al. Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis , 2017, Therapeutics and clinical risk management.
[4] Marco Beccuti,et al. From Symmetric Nets to Differential Equations exploiting Model Symmetries , 2015, Comput. J..
[5] Marco Beccuti,et al. GreatSPN Enhanced with Decision Diagram Data Structures , 2010, Petri Nets.
[6] Giovanni Chiola,et al. Stochastic Well-Formed Colored Nets and Symmetric Modeling Applications , 1993, IEEE Trans. Computers.
[7] Carlo Alberto Artusi,et al. Natalizumab in Multiple Sclerosis: Long-Term Management , 2017, International journal of molecular sciences.
[8] A. Saltelli,et al. Sensitivity analysis for chemical models. , 2005, Chemical reviews.
[9] D. Kirschner,et al. A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.
[10] T. Kurtz. Strong approximation theorems for density dependent Markov chains , 1978 .
[11] Marco Ajmone Marsan,et al. Modelling with Generalized Stochastic Petri Nets , 1995, PERV.
[12] Abdul Mateen Rajput,et al. Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis , 2013, BMC Bioinformatics.
[13] B. Trapp,et al. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis , 2011, Progress in neurobiology.
[14] Marco Beccuti,et al. GPU Accelerated Analysis of Treg-Teff Cross Regulation in Relapsing-Remitting Multiple Sclerosis , 2018, Euro-Par Workshops.
[15] Richard J. Beckman,et al. A Comparison of Three Methods for Selecting Values of Input Variables in the Analysis of Output From a Computer Code , 2000, Technometrics.
[16] B. Trapp,et al. Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.
[17] Peter Sundström,et al. Rituximab in multiple sclerosis , 2016, Neurology.